Notice of Intent to Publish a Funding Opportunity Announcement for CCRP Initiative: Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early-Stage Development (UG3/UH3 Clinical Trial Not Allowed)

The NIH Countermeasures Against Chemical Threats (CounterACT) program intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for the early-stage development of therapeutics to mitigate the adverse health effects resulting from toxic chemical exposure.This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.The NOFO is expected to be published in early 2025 with an expected application due date in October 2025.This NOFO will utilize the phased UG3/UH3 activity code. Preliminary details of the planned NOFO are provided below.